FCF1P9

Across TCGA pan-cancer cohorts, FCF1P9 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated FCF1P9 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher FCF1P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FCF1P9 expression acts as an unfavorable survival marker.

BRCA, UCEC, and READ are the cancer types where FCF1P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.130	0.579	<.001	114	view →
UCEC	OS	Tertile	All	0.774	0.927	.011	60	view →
READ	DFS	Tertile	All	0.269	0.819	.009	45	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRC	DFS	Tertile	IV	0.083	0.641	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FCF1P9–BRCA (OS)

Open the BRCA breakdown →